EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correction to “A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms”

MedComm – Biomaterials and Applications · 2026-12 · 5 (4)

DOI: 10.1002/mba2.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Biomaterials and Applications, online erschienen am 03.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms”. MedComm – Biomaterials and Applications, 5(4). https://doi.org/10.1002/mba2.70109

Vancouver

Correction to “A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms”. MedComm – Biomaterials and Applications. 2026;5(4). doi:10.1002/mba2.70109

BibTeX
@article{euvimed2026,
  title = {Correction to “A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms”},
  journal = {MedComm – Biomaterials and Applications},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.1002/mba2.70109}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche